SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Leone Marc)
 

Sökning: WFRF:(Leone Marc) > (2020-2024) > Defining Comprehens...

Defining Comprehensive Disease Control for use as a Treatment Target for Ulcerative Colitis in Clinical Practice : International Delphi Consensus Recommendations

Schreiber, Stefan (författare)
University Hospital Schleswig-Holstein, Department of Internal Medicine I, Kiel, Germany
Danese, Silvio (författare)
IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy
Dignass, Axel (författare)
Department of Medicine I, Agaplesion Markus Hospital, Goethe University, Frankfurt, Germany
visa fler...
Domènech, Eugeni (författare)
Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol and CIBEREHD, Badalona, Spain; Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain
Fantini, Massimo C. (författare)
Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy
Ferrante, Marc (författare)
Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium
Halfvarson, Jonas, 1970- (författare)
Örebro universitet,Institutionen för medicinska vetenskaper,Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
Hart, Ailsa (författare)
St. Mark's Hospital, Greater London, UK
Magro, Fernando (författare)
CINTESIS@RISE, Faculty of Medicine of the University of Porto, Porto, Portugal
Lees, Charlie W. (författare)
Edinburgh Inflammatory Bowel Disease Unit, Western General Hospital, Edinburgh, UK
Leone, Salvo (författare)
European Federation of Crohn's & Ulcerative Colitis Associations (EFCCA), Brussels, Belgium
Pierik, Marieke J. (författare)
Division Gastroenterology and Hepatology, Maastricht University Medical Centre, Maastricht, Netherlands
Peters, Michele (författare)
Nuffield Department of Population Health, University of Oxford, Oxford, UK
Field, Polly (författare)
Oxford PharmaGenesis, Oxford, UK
Fishpool, Helen (författare)
Oxford PharmaGenesis, Oxford, UK
Peyrin-Biroulet, Laurent (författare)
Department of Gastroenterology, Nancy University Hospital, Vandœuvre-lès-Nancy,France; Inserm, NGERE, University of Lorraine, Nancy, France; INFINY Institute, Nancy University Hospital, Vandœuvre-lès-Nancy, France; FHU-CURE, Nancy University Hospital, Vandœuvre-lès-Nancy, France; Groupe Hospitalier privé Ambroise Paré - Hartmann, Paris IBD Center, Neuilly sur Seine, France; Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Quebec, Canada
visa färre...
 (creator_code:org_t)
Oxford University Press, 2024
2024
Engelska.
Ingår i: Journal of Crohn's & Colitis. - : Oxford University Press. - 1873-9946 .- 1876-4479. ; 18:1, s. 91-105
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • BACKGROUND AND AIMS: Treatment of ulcerative colitis (UC) requires a patient-centric, definition of comprehensive disease control that considers improvements in aspects not typically captured by classical landmark trial endpoints. In an international initiative we reviewed aspects of UC that affect patients and/or indicate mucosal inflammation, to achieve consensus on which aspects to combine in a definition of comprehensive disease control, using a modified Delphi process.METHODS: The Delphi panel comprised 12 gastroenterologists and one patient advocate. Two gastroenterologists were elected as chairs and did not vote. To inform statements, we asked 18 patients and the panel members about their experiences of remission and reviewed published literature. Panel members voted on statements anonymously in three rounds, with a live discussion before round 3. Consensus was met if ≥ 67% of the panel agreed. Statements without consensus in rounds 1 and 2 were revised or discarded after round 3.RESULTS: The panel agreed to measure individual patient benefit using a definition of comprehensive disease control that combines aspects currently measured in trials (rectal bleeding, stool frequency, disease-related quality of life, endoscopy, histological inflammatory activity, inflammatory biomarkers, and corticosteroid use), with additional patient-reported symptoms (bowel urgency, abdominal pain, extraintestinal manifestations, fatigue, and sleep disturbance). The panel agreed on scoring systems and thresholds for many aspects.CONCLUSIONS: Using a robust methodology, we defined comprehensive disease control in UC. Next, we will combine the measurement and scoring of these aspects into a multi-component tool and adopt comprehensive disease control as a treatment target in clinical practice and trials.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Gastroenterologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Gastroenterology and Hepatology (hsv//eng)

Nyckelord

Delphi consensus
Ulcerative colitis
patient-reported symptoms
remission

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy